AzTrials
AzTrials

Weight BiasNCT07334470

Weight Bias Reducation Intervention With Nursing Students Using Simulation: The BRAVE Study

A study testing BRAVE and SOL: Standard Obesity Lecture in people with Weight Bias, run by Villanova University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial will be a curriculum-embedded weight sensitivity training program. There will be two groups. The control group will receive the standard obesity lecture (SOL) and the intervention group will receive the BRAVE Intervention (BRAVE: Building Respect and Acceptance through Valuing… Read more about this study

Who is it for?
Ages 18 to 35 years
Conditions the study is for
Weight Bias
What is being tested?
BRAVE and SOL: Standard Obesity Lecture
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
368 participants
Where
1 siteUnited States
Study dates
12 Jan 2026to 20 May 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Nursing students aged 18-35
  • Nursing students during their second or fourth year of the traditional or FLEX BSN undergraduate curriculum (in specified nursing courses)

Who cannot join

  • Non-nursing students
  • Nursing students taking courses out of the normal curriculum sequence
  • Nursing students who are not of traditional undergraduate ages (18-35 years)
  • Students who decline to consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Tracy L. Oliver, PhD, RDN, LDN contact

610-519-4917

tracy.oliver@villanova.edu

United States1 site, 1 recruiting
  • Villanova University

    Villanova, Pennsylvania, 19085-1603

    Tracy Oliver, PhD, RDN, LDN, 610-519-4917, tracy.oliver@villanova.edu

    Bette Mariani, PhD, RN, ANEF, FAAN, 610-519-4933, Bette.Mariani@villanova.edu

    Recruiting

Other trials in United States

About this study

Official title: The BRAVE Study: A Sensitivity Intervention With Nursing Students Using Simulation

This randomized controlled trial will be a curriculum-embedded weight sensitivity training program. There will be two groups. The control group will receive the standard obesity lecture (SOL) and the intervention group will receive the BRAVE Intervention (BRAVE: Building Respect and Acceptance through Valuing Everybody); a Weight Bias Reduction (WBR) intervention. Both groups will have two simulation encounters with standardized patients who are living with obesity and the outcome will be to improve weight bias and increase weight sensitivity over one year. Participants will include second- and fourth-year nursing students. Two cohorts of nursing students will be recruited over two years during orientation for their NUR courses (n = 368); a combined total of 420 students are typically enrolled in these courses. Study participants will be randomized by 8-person simulation groups (clusters) to either the BRAVE intervention or SOL control group. They will then participate in the two simulation-based experiences and weight bias reduction education or standard obesity lecture, respectively, with a debriefing segment and educational components. To compare the efficacy of BRAVE groups to SOL groups in validated questionnaires will assess changing attitudes, beliefs, and clinical communication behaviors when comparing baseline to 3 months post-intervention, and one year after the intervention.

Read the detailed description

Longstanding evidence documents the detrimental effects of provider biases on poor patient outcomes. Weight bias among nurses is an understudied concept that causes increased morbidity and mortality in populations living with obesity. Specifically, studies show that nurses with weight bias: 1) assume patients' symptoms are related to obesity and do not further probe underlying causes, 2) are more reluctant to perform preventative health screenings (such as pelvic examinations, cancer screenings, and mammograms), 3) spend less time engaging with patients during visits, all of which causes patients to withdraw from the provider, potentially resulting in difficulty remembering or adhering to provider advice and avoiding future preventative care visits.

Given the increasing rates of obesity in the United States, efforts are direly needed to improve the care provided by nurses who work with this demographic to thwart preventable health consequences (e.g., diabetes, heart disease). Our previous research showed favorable improvements in nursing students' attitudes and beliefs toward individuals with obesity following a Weight Bias Reduction (WBR) intervention when implemented into their clinical course. Gaps remain, however, in 1) whether WBR interventions can translate into behavior change in clinical practice and make notable reductions in the weight bias patients are experiencing, and 2) whether these changes are sustained over time. To fill these gaps, the proposed BRAVE (Building Respect and Acceptance through Valuing Everybody, WBR intervention) will build on our previous research to include education on communication skills and empathic competence, as well as utilize simulation with standardized participants living with obesity.

The study design is a cluster-randomized controlled trial comparing BRAVE to SOL (Standard Obesity Lecture) in reducing weight bias among nursing students (n = 368) and will include follow-up measures to determine the intervention's sustained effects one year later. Additionally, the broader impacts of this BRAVE intervention can enhance long-term health outcomes with the potential for improved patient satisfaction while navigating the healthcare system.

AIM 1: To compare the efficacy of BRAVE groups to SOL groups in changing attitudes, beliefs, and clinical communication behaviors when comparing baseline to 3 months post-intervention.

Hypothesis 1: BRAVE groups will demonstrate statistically significant improvements in attitudes, beliefs, and clinical communication behaviors that are greater than those of SOL groups when comparing baseline and 3 months post-intervention.

  • Attitudes will be measured by Attitudes Towards Higher Weight Persons (ATOP-HW) Questionnaire scores.
  • Beliefs will be measured by Beliefs About Obese Persons (BAOP) Questionnaire scores.
  • Clinical Communication Behaviors will be measured by SE-12, WSI, and SEGUE scores.

AIM 2: To evaluate whether changes in attitudes, beliefs, and clinical communication behaviors between BRAVE and SOL groups are sustained over a one-year period.

Hypothesis 2: BRAVE groups will sustain statistically significant improvements in attitudes, beliefs, and clinical communication behaviors toward obesity compared to SOL groups when assessed from Session 2 to Session 3 one year post-intervention.

Attitudes will be measured by Attitudes Towards Higher Weight Persons (ATOP-HW) Questionnaire scores.

Beliefs will be measured by the Beliefs About Obese Persons (BAOP) Questionnaire scores.

Clinical Communication Behaviors (self-efficacy) will be measured by the SE-12 scores.

Conditions
Weight Bias
Being tested
BRAVE, SOL: Standard Obesity Lecture
Keywords
weight bias, nursing education, obesity
Medical subject headings
Weight Prejudice, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BRAVEBehavioural

    In addition to the two simulation encounters, the BRAVE arm will include an initial one-hour educational presentation on weight bias in health care; prevalence, and influences of weight bias on health/health care, factors affecting obesity, approaching weight-related discussions with patients with sensitivity and empathy, and effective communication strategies. Clinical communication behaviors will also be taught, such as asking permission, using non-stigmatizing language, and engaging in judgment-free weight-related discussions with patients. They will also have role-play and case-study scenarios to integrate and practice the communication strategies. Following the second simulation and DML, students in the BRAVE arm will participate in a continuation of the weight bias reduction education including concepts of Motivational Interviewing, Shared Decision Making, and weight management conversations to prevent weight bias in the clinical environment.

  • SOL: Standard Obesity LectureBehavioural

    SOL: (Standard Obesity Lecture) SOL arm education will include a presentation on obesity as a disease, its prevalence, causes, health risks, psychological and socioeconomic impact, and a standard obesity assessment. Following the second simulation, students in the SOL groups will participate in a continuation of the standard obesity education to build on concepts from session 1. The second presentation will be a recap on weight management in clinical practice. Readings will focus on the medical consequences of obesity, and the economic cost of obesity. Both Debriefing for Meaningful Learning segments will focus on the disease itself and not include components of obesity or body weight.

Study groups in NCT07334470
Study groupRoleWhat they receive
BRAVE InterventionExperimentalBRAVE (Building Respect and Acceptance through Valuing Everybody). Participants will receive two 30-minute Simulated Patients (SP) encounters: 1 at baseline (before the weight bias or obesity presentations) and one at 1.5 months after the initial education. The simulation encounters will include SPs living with higher body weight and will emphasize communication skills to prevent weight bias in the clinical environment. BRAVE arm will consist of two educational sessions focused on reducing weight bias in health care. Both BRAVE SP encounters will provide a Debriefing for Meaningful Learning segment tailored to focus on reducing weight bias.
Receives: Behavioral: BRAVE
SOLPlacebo comparatorSOL (Standard Obesity Lecture). The control arm will experience two standard obesity lectures and two simulation encounters with standardized patients living with higher body weight. The control condition consists of two sessions, each of which includes a one-hour presentation on obesity. Both simulations will be followed by standard Debriefing for Meaningful Learning segments, but these segments will focus only on the medical conditions and risk factors of obesity and no feedback on communication skills will be provided.
Receives: Behavioral: SOL: Standard Obesity Lecture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attitudes Towards Higher Weight Persons (ATOP-HW)

    Estimated Mean Change Score.The ATOP-HW is a 20-item Likert rating scale that focuses on perceptions and attitudes about people living with obesity. Higher scores reflect more positive attitudes toward persons with obesity.

    Measured: Baseline to 3 Months

  2. Beliefs About Obese Persons Scale (BAOP)

    The BAOP is an eight-item Likert rating scale that assesses beliefs about the causes of obesity. Each question asks individuals to indicate the extent of agreement or disagreement (+3 to -3) to a specific statement, such as "obesity is really caused by a lack of willpower." Higher scores indicate beliefs that obesity is not controllable.

    Measured: Baseline to 3 Months

  3. SE-12 (Self-Efficacy) Scale

    The SE-12 is a 12-item questionnaire assessing self-efficacy by clinicians in clinical communications.

    Measured: Baseline to 3 Months

Secondary outcomes (5)
  1. SEGUE Framework

    The SEGUE Checklist is a valid and reliable checklist designed to be used in various settings to teach, assess, and improve communication skills with medical providers.The SEGUE acronym stands for Set the Stage, Elicit information, Give information, Understand the patient's perspective, and End the encounter. SEGUE includes a 25-item dichotomous checklist to evaluate whether a task was completed.

    Measured: Baseline and 3 Months

  2. Weight Sensitivity Instrument (WSI)

    The WSI is a 15-item checklist that will assess aspects of physical assessment skills, patient psychological safety, and weight sensitivity of the session.

    Measured: Baseline and 3 Months

  3. Attitudes Towards Higher Weight Persons (ATOP-HW) Questionnaire

    The ATOP-HW is a 20-item Likert rating scale that focuses on perceptions and attitudes about obese people. Higher scores reflect more positive attitudes toward persons with obesity.

    Measured: Baseline to 1 Year; 3 months to 1 Year

  4. Beliefs About Obese Persons Scale (BAOP)

    The BAOP is an eight-item Likert rating scale that assesses beliefs about the causes of obesity. Each question asks individuals to indicate the extent of agreement or disagreement (+3 to -3) to a specific statement, such as "obesity is really caused by a lack of willpower." Higher scores indicate beliefs that obesity is not controllable

    Measured: Baseline to 1 Year; 3 months to 1 year

  5. SE-12 (Self-Efficacy) Questionnaire

    The SE-12 is a 12-item questionnaire assessing self-efficacy by clinicians in clinical communications.

    Measured: Baseline to 1 year; 3 months to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2026
  2. Study start12 Jan 2026
  3. Primary completion20 May 2028 (estimated)
  4. Study completion20 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
368 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07334470
Sponsor's protocol ID
IRB-FY2025-30
Status last verified
Jan 2026
First submitted
30 Dec 2025
Last updated
17 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Geller G, Watkins PA. Addressing Medical Students' Negative Bias Toward Patients With Obesity Through Ethics Education. AMA J Ethics. 2018 Oct 1;20(10):E948-959. doi: 10.1001/amajethics.2018.948.

    PubMed 30346923
  • Gayer GG, Weiss J, Clearfield M. Fundamentals for an Osteopathic Obesity Designed Study: The Effects of Education on Osteopathic Medical Students' Attitudes Regarding Obesity. J Am Osteopath Assoc. 2017 Aug 1;117(8):495-502. doi: 10.7556/jaoa.2017.099.

    PubMed 28759091
  • Charlesworth TES, Banaji MR. Patterns of Implicit and Explicit Attitudes: I. Long-Term Change and Stability From 2007 to 2016. Psychol Sci. 2019 Feb;30(2):174-192. doi: 10.1177/0956797618813087. Epub 2019 Jan 3.

    PubMed 30605364
  • Bell ML, Rabe BA. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data. Trials. 2020 Feb 7;21(1):148. doi: 10.1186/s13063-020-4114-9.

    PubMed 32033617
  • Makoul G. The SEGUE Framework for teaching and assessing communication skills. Patient Educ Couns. 2001 Oct;45(1):23-34. doi: 10.1016/s0738-3991(01)00136-7.

    PubMed 11602365
  • Axboe MK, Christensen KS, Kofoed PE, Ammentorp J. Development and validation of a self-efficacy questionnaire (SE-12) measuring the clinical communication skills of health care professionals. BMC Med Educ. 2016 Oct 18;16(1):272. doi: 10.1186/s12909-016-0798-7.

    PubMed 27756291
  • Allison, D.B., Basile, V.C., & Yuker, H.E. (1991). The measurement of attitudes toward and beliefs about obese persons. International Journal of Eating Disorders, 10(5). 599-607

  • Dreifuerst, K. T. (2015). Getting started with debriefing for meaningful learning. Clinical Simulation in Nursing, 11(5), 268-275. http://dx.doi.org/10.1016/j.ecns.2015.01.005

  • Douglas, V.J., Kwan, M.Y., Minnich, A.M., Converse, J.N., Wonderlich, J.A., & Gordon, K.H. (2022). An examination of the link between empathy and weight-based victimization. Social Sciences & Humanities Open, 5(1), 100247 https://doi.org/10.1016/j.ssaho.2022.100247

  • Burke SE, Dovidio JF, Przedworski JM, Hardeman RR, Perry SP, Phelan SM, Nelson DB, Burgess DJ, Yeazel MW, van Ryn M. Do Contact and Empathy Mitigate Bias Against Gay and Lesbian People Among Heterosexual First-Year Medical Students? A Report From the Medical Student CHANGE Study. Acad Med. 2015 May;90(5):645-51. doi: 10.1097/ACM.0000000000000661.

    PubMed 25674910
  • Dovidio, J.F., Gaertner, S.L., & Kawakami, K. (2003). Intergroup contact: the past, present, and future. Group Process Intergroup Relations, 6, 5-21.

  • Pettigrew TF, Tropp LR. A meta-analytic test of intergroup contact theory. J Pers Soc Psychol. 2006 May;90(5):751-83. doi: 10.1037/0022-3514.90.5.751.

    PubMed 16737372
  • Allport, G.W. (1954). The Nature of Prejudice, Reading, Massachusetts: Addison-Wesley

  • Phelan SM, Puhl RM, Burgess DJ, Natt N, Mundi M, Miller NE, Saha S, Fischer K, van Ryn M. The role of weight bias and role-modeling in medical students' patient-centered communication with higher weight standardized patients. Patient Educ Couns. 2021 Aug;104(8):1962-1969. doi: 10.1016/j.pec.2021.01.003. Epub 2021 Jan 5.

    PubMed 33487507
  • Kushner RF, Zeiss DM, Feinglass JM, Yelen M. An obesity educational intervention for medical students addressing weight bias and communication skills using standardized patients. BMC Med Educ. 2014 Mar 18;14:53. doi: 10.1186/1472-6920-14-53.

    PubMed 24636594

Questions about this trial

What is this clinical trial studying?

A study testing BRAVE and SOL: Standard Obesity Lecture in people with Weight Bias, run by Villanova University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tracy L. Oliver, PhD, RDN, LDN (610-519-4917, tracy.oliver@villanova.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attitudes Towards Higher Weight Persons (ATOP-HW) (time frame: Baseline to 3 Months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07334470, which also lists 62 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in